Zurich, Switzerland – As of January 1, Hans Geiselhöringer has taken over as President of Nobel Biocare. 

Since 2011, Hans Geiselhöringer has served as Executive Vice President of Global Research, Products and Development, shaping a highly competitive product and innovation pipeline. Prior to that he was Executive Vice President, Global Marketing and Products from 2010–2011 and Head of NobelProcera and Guided Surgery from 2009–2010. Hans joined Nobel Biocare as Head of NobelProcera in 2008 and was appointed a member of the executive committee in 2009.

From 2004 to 2009, Hans acted as a Global Speaker for Nobel Biocare and with this appointment, he becomes the first Nobel Biocare customer and dental expert in the company’s history to take the reigns as its highest ranking executive.

In 1998, he founded DentalX GmbH, a dental laboratory chain specializing in implantology, anaplastology, functional and esthetic reconstructions, and imaging technologies. Hans is a trained Dental Technician and possesses great technical knowledge of the implant and CAD/CAM industries, as well as customer understanding and insights. As an expert on dental technologies and materials, he has published/co-published various clinical and research articles. He is also a member of numerous international dental associations and a recognized lecturer at dental conventions throughout the world.

Hans Geiselhöringer, President, Nobel Biocare, said, “Our focus on the patient remains steadfast and constant. Everything we do will continue to be patient-centered, clinically relevant, and evidence based. To strengthen our leadership in implant-based dentistry, we strongly focus on providing integrated digital solutions to improve the customer experience and increase productivity on all levels while ensuring a high level of clinical success and predictability. With our counterparts at KaVo Kerr Group, we have all the pieces in place today and we are grouping our highly skilled global teams together to form the industry’s new digital dentistry powerhouse. In summary, we at Nobel Biocare will continue our strong commitment to innovation, providing an ongoing pipeline of superior solutions that helps more customers treat more patients better.”